Function Health's $2.5 Billion Bet And Are Blood Testing Startups Sustainable [Forbes]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Forbes
But behind the impressive headline lies a more complex question about the sustainability of the direct-to-consumer lab testing boom. The Numbers Tell A Complex Story Using the 50 million tests figure, we can reverse-engineer Function's approximate revenue trajectory. With around 100 tests per panel and members testing twice yearly, this translates to roughly 250,000 paid member-years at $499 per membership, suggesting approximately $125 million in cumulative revenue over three years. If revenue growth accelerated recently, the company likely generated $50-75 million in the last twelve months alone. At a $2.5 billion valuation, Function commands a 30-50x multiple on trailing revenue. While ambitious for most businesses, such valuations aren't unprecedented in the longevity space, where investors bet on future potential rather than current economics. Yet Function's competitive environment raises questions about whether these numbers can grow sustainably. A Crowded Market Gets
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States [Yahoo! Finance]Yahoo! Finance
- Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United StatesBusiness Wire
- Quest Diagnostics (DGX): A Fresh Look at Valuation After Strong Q3 Earnings and Raised Outlook [Yahoo! Finance]Yahoo! Finance
- How the Narrative Around Quest Diagnostics Is Evolving After Recent Results and Analyst Updates [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics declares $0.80 dividend [Seeking Alpha]Seeking Alpha
DGX
Earnings
- 10/21/25 - Beat
DGX
Sec Filings
- 11/28/25 - Form 4
- 11/28/25 - Form 4
- 11/25/25 - Form 144
- DGX's page on the SEC website